Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study)

• Main Authors: Yuichi Tamura (Author), Hiraku Kumamaru (Author), Ichizo Tsujino (Author), Rika Suda (Author), Kohtaro Abe (Author), Takumi Inami (Author), Koshin Horimoto (Author), Shiro Adachi (Author), Satoshi Yasuda (Author), Fusako Sera (Author), Yu Taniguchi (Author), Masataka Kuwana (Author), Koichiro Tatsumi (Author)
• Format: Book
• Published: MDPI AG, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pulmonary arterial hypertension (PAH) remains a significant challenge in cardiology, necessitating advancements in treatment strategies. This study explores the safety and efficacy of transitioning patients from beraprost to selexipag, a novel selective prostacyclin receptor agonist, within a Japane...